Arch Venture Partners X, Llc - Net Worth and Insider Trading

In summary, during the past 3 months, insiders sold 0 shares of Sienna Biopharmaceuticals Inc (SNNAQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sienna Biopharmaceuticals Inc (SNNAQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sienna Biopharmaceuticals Inc (SNNAQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Arch Venture Partners X, Llc made no insider transaction in Erasca Inc (ERAS). Other recent insider transactions involving Erasca Inc (ERAS) include a net purchase of 2,300,000 shares made by Jonathan E Lim , a net purchase of 150,000 shares made by Alexander W. Casdin , and a net purchase of 615,384 shares made by Bihua Chen .

In summary, during the past 3 months, insiders sold 0 shares of Erasca Inc (ERAS) in total and bought 80,000 shares, with a net purchase of 80,000 shares. During the past 18 months, 0 shares of Erasca Inc (ERAS) were sold and 3,105,384 shares were bought by its insiders, resulting in a net purchase of 3,105,384 shares.

Erasca Inc (ERAS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Arch Venture Partners X, Llc made no insider transaction in Sana Biotechnology Inc (SANA). Other recent insider transactions involving Sana Biotechnology Inc (SANA) include a net sale of 949,000 shares made by Flagship Ventures Fund V, L.p. , a net purchase of 1,818,181 shares made by Keith Crandell , and a net purchase of 1,818,181 shares made by Robert Nelsen .

In summary, during the past 3 months, insiders sold 25,000 shares of Sana Biotechnology Inc (SANA) in total and bought 0 shares, with a net sale of 25,000 shares. During the past 18 months, 1,049,000 shares of Sana Biotechnology Inc (SANA) were sold and 5,454,543 shares were bought by its insiders, resulting in a net purchase of 4,405,543 shares.

Sana Biotechnology Inc (SANA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Arch Venture Partners X, Llc made no insider transaction in Verve Therapeutics Inc (VERV). Other recent insider transactions involving Verve Therapeutics Inc (VERV) include a net purchase of 1,800,000 shares made by Krishna Yeshwant , a net purchase of 76,000 shares made by Andrew D. Ashe , and a net sale of 1,514 shares made by Joan Nickerson .

In summary, during the past 3 months, insiders sold 1,514 shares of Verve Therapeutics Inc (VERV) in total and bought 76,000 shares, with a net purchase of 74,486 shares. During the past 18 months, 2,068 shares of Verve Therapeutics Inc (VERV) were sold and 1,876,000 shares were bought by its insiders, resulting in a net purchase of 1,873,932 shares.

Verve Therapeutics Inc (VERV)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Arch Venture Partners X, Llc made 1 insider transaction in Prime Medicine Inc (PRME) with a net purchase of 3,200,000. Other recent insider transactions involving Prime Medicine Inc (PRME) include a net sale of 1,422,190 shares made by Gv 2019 Gp, L.l.c. , a net purchase of 3,200,000 shares made by Arch Venture Partners Xii, Llc , and a net purchase of 3,200,000 shares made by Robert Nelsen .

In summary, during the past 3 months, insiders sold 0 shares of Prime Medicine Inc (PRME) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,422,190 shares of Prime Medicine Inc (PRME) were sold and 9,600,000 shares were bought by its insiders, resulting in a net purchase of 8,177,810 shares.

Prime Medicine Inc (PRME)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Arch Venture Partners X, Llc made 1 insider transaction in Neumora Therapeutics Inc (NMRA) with a net purchase of 1,500,000. Other recent insider transactions involving Neumora Therapeutics Inc (NMRA) include a net purchase of 2,007,064 shares made by Kristina Burow , a net purchase of 507,064 shares made by Arch Venture Partners Xii, Llc , and a net purchase of 1,764,705 shares made by Amgen Inc .

In summary, during the past 3 months, insiders sold 0 shares of Neumora Therapeutics Inc (NMRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Neumora Therapeutics Inc (NMRA) were sold and 7,293,833 shares were bought by its insiders, resulting in a net purchase of 7,293,833 shares.

Neumora Therapeutics Inc (NMRA)'s detailed insider trading history can be found in Insider Trading Tracker table.